Prognostic value of cytokines and chemokines in addition to the GRACE Score in non-ST-elevation acute coronary syndromes

Clinica Chimica Acta

Volumn 411, Issue 7-8, 2010, Pages 540-545

  Correia, Luis C L ^b,c   Andrade, Bruno B ^a   Borges, Valéria M ^a   Clarêncio, Jorge ^a   Bittencourt, Ana P ^b   Freitas, Rafael ^b   Souza, Alexandre C ^b   Almeida, Maria C ^b   Leal, Jamile ^b   Esteves, J Péricles ^c   Barral Netto, Manoel ^a,d  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Portuguese Hospital   (Brazil)

^c Medical School of Bahia   (Brazil)

^d Institute of Investigation in Immunology (iii)   (Brazil)

Author keywords

Acute coronary syndromes; C reactive protein; Chemokines; Cytokines

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CHEMOKINE; CLOPIDOGREL; CXCL9 CHEMOKINE; CYTOKINE; ENOXAPARIN; FIBRINOGEN RECEPTOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY ARTERY BYPASS SURGERY; FEMALE; HEART INFARCTION; HOSPITALIZATION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; SYSTOLE; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; C-REACTIVE PROTEIN; CHEMOKINES; CYTOKINES; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

ANGINA;

EID: 77649190432     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.01.011     Document Type: Article

References (34)

1. Yan A.T., Yan R.T., Huynh T., et al. Understanding physicians' risk stratification of acute coronary syndromes: insights from the Canadian ACS 2 Registry. Arch Intern Med 2009, 169:372-378.
2. de Araujo G.P., Ferreira J., Aguiar C., Seabra-Gomes R. TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J 2005, 26:865-872.
3. Yan A.T., Yan R.T., Tan M., et al. Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better. Eur Heart J 2007, 28:1072-1078.
4. Armstrong E.J., Morrow D.A., Sabatine M.S. Inflammatory biomarkers in acute coronary syndromes: part I: introduction and cytokines. Circulation 2006, 113:e72-e75.
5. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107:499-511.
6. O'Donoghue M., Morrow D.A. The future of biomarkers in the management of patients with acute coronary syndromes. Curr Opin Cardiol 2008, 23:309-314.
7. Correia L.C., Lima J.C., Rocha M.S., D'Oliveira J.A., Pericles E.J. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?. Clin Chim Acta 2007, 375:124-128.
8. Apple F.S., Quist H.E., Doyle P.J., Otto A.P., Murakami M.M. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology Consensus Recommendations. Clin Chem 2003, 49:1331-1336.
9. Granger C.B., Goldberg R.J., Dabbous O., et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003, 163:2345-2353.
10. Chen R., Lowe L., Wilson J.D., et al. Simultaneous quantification of six human cytokines in a single sample using microparticle-based flow cytometric technology. Clin Chem 1999, 45:1693-1694.
11. Spinas G.A., Keller U., Brockhaus M. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. J Clin Invest 1992, 90:533-536.
12. Rifai N., Tracy R.P., Ridker P.M. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999, 45:2136-2141.
13. Pencina M.J., D'Agostino R.B., D'Agostino R.B., Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27:157-172.
14. Kraaijeveld A.O., de Jager S.C.A., de Jager W.J., et al. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms. Circulation 2007, 116:1931-1941.
15. de Jager S.C., Kraaijeveld A.O., Grauss R.W., et al. CCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events. J Mol Cell Cardiol 2008, 45:446-452.
16. de Lemos J.A., Morrow D.A., Sabatine M.S., et al. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 2003, 107:690-695.
17. Kervinen H., Manttari M., Kaartinen M., et al. Prognostic usefulness of plasma monocyte/macrophage and T-lymphocyte activation markers in patients with acute coronary syndromes. Am J Cardiol 2004, 94:993-996.
18. de Lemos J.A., Morrow D.A., Blazing M.A., et al. Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial. J Am Coll Cardiol 2007, 50:2117-2124.
19. Jaremo P., Nilsson O. Interleukin-6 and neutrophils are associated with long-term survival after acute myocardial infarction. Eur J Intern Med 2008, 19:330-333.
20. Malarstig A., Eriksson P., Hamsten A., Lindahl B., Wallentin L., Siegbahn A. Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome. Heart 2008, 94:724-729.
21. Tziakas D.N., Chalikias G.K., Kaski J.C., et al. Inflammatory and anti-inflammatory variable clusters and risk prediction in acute coronary syndrome patients: a factor analysis approach. Atherosclerosis 2007, 193:196-203.
22. Chalikias G.K., Tziakas D.N., Kaski J.C., et al. Interleukin-18/interleukin-10 ratio is an independent predictor of recurrent coronary events during a 1-year follow-up in patients with acute coronary syndrome. Int J Cardiol 2007, 117:333-339.
23. Kavsak P.A., Ko D.T., Newman A.M., et al. Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide. Clin Chem 2007, 53:2112-2118.
24. Hartford M., Wiklund O., Mattsson H.L., et al. C-reactive protein, interleukin-6, secretory phospholipase A2 group IIA and intercellular adhesion molecule-1 in the prediction of late outcome events after acute coronary syndromes. J Intern Med 2007, 262:526-536.
25. Kilic T., Ural D., Ural E., et al. Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome. Heart 2006, 92:1041-1046.
26. Lee K.W., Lip G.Y., Tayebjee M., Foster W., Blann A.D. Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. Blood 2005, 105:526-532.
27. Heeschen C., Dimmeler S., Hamm C.W., et al. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 2003, 107:2109-2114.
28. Rallidis L.S., Zolindaki M.G., Manioudaki H.S., Laoutaris N.P., Velissaridou A.H., Papasteriadis E.G. Prognostic value of C-reactive protein, fibrinogen, interleukin-6, and macrophage colony stimulating factor in severe unstable angina. Clin Cardiol 2002, 25:505-510.
29. Anguera I., Miranda-Guardiola F., Bosch X., et al. Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable angina. Am Heart J 2002, 144:811-817.
30. Koukkunen H., Penttila K., Kemppainen A., et al. C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris. Ann Med 2001, 33:37-47.
31. Biasucci L.M., Liuzzo G., Fantuzzi G., et al. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 1999, 99:2079-2084.
32. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
33. Delves P.J., Roitt I.M. The immune system. Second of two parts. N Engl J Med 2000, 343:108-117.
34. Aukrust P., Halvorsen B., Yndestad A., et al. Chemokines and cardiovascular risk. Arterioscler Thromb Vasc Biol 2008, 28:1909-1919.